BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22:329-339. [PMID: 23316916 DOI: 10.1517/13543784.2013.761205] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Ghoshal U, Biswas SN, Dixit VK, Yadav JS. Anxiety and depression in Indian patients with irritable bowel syndrome: A meta-analysis. Indian J Gastroenterol 2023. [PMID: 36656484 DOI: 10.1007/s12664-022-01300-0] [Reference Citation Analysis]
2 Mazumder S, Bindu S, De R, Debsharma S, Pramanik S, Bandyopadhyay U. Emerging role of mitochondrial DAMPs, aberrant mitochondrial dynamics and anomalous mitophagy in gut mucosal pathogenesis. Life Sci 2022;:120753. [PMID: 35787999 DOI: 10.1016/j.lfs.2022.120753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Laroute V, Beaufrand C, Gomes P, Nouaille S, Tondereau V, Daveran-Mingot ML, Theodorou V, Eutamene H, Mercier-Bonin M, Cocaign-Bousquet M. Lactococcus lactis NCDO2118 exerts visceral antinociceptive properties in rat via GABA production in the gastro-intestinal tract. Elife 2022;11:e77100. [PMID: 35727704 DOI: 10.7554/eLife.77100] [Reference Citation Analysis]
4 Yu Z, Liu L, Lai Y, Tian Z, Yang L, Zhang Q, Liang F, Yu S, Zheng Q. Altered Resting Brain Functions in Patients With Irritable Bowel Syndrome: A Systematic Review. Front Hum Neurosci 2022;16:851586. [DOI: 10.3389/fnhum.2022.851586] [Reference Citation Analysis]
5 Ivashkin VT, Shelygin YA, Baranskaya EK, Achkasov SI, Belous SS, Belousova EA, Beniashviili AG, Vasiliev SV, Grigoriev EG, Kostenko NV, Moskalev AI, Kashnikov VN, Loranskaya ID, Lyashenko OS, Poluektova EA, Rumyantsev VG, Timerbulatov VM, Chashkova EY, Shapina MV, Sheptulin AA, Shifrin OS, Zolnikova OY, Baranovsky AY, Korochanskaya NV, Mammaev SN, Alekseeva OP, Khlynov IB, Tsukanov VV, Alekseenko SA. Irritable bowel syndrome. Koloproktologiâ 2022;21:10-25. [DOI: 10.33878/2073-7556-2022-21-1-10-25] [Reference Citation Analysis]
6 Ivashkin VT, Maev IV, Shelygin YA, Baranskaya EK, Belous SS, Belousova EA, Beniashvili AG, Vasilyev SV, Veselov AV, Grigoryev EG, Kostenko NV, Kashnikov VN, Kulikovskiy VF, Loranskaya ID, Lyashenko OS, Poluektova EA, Rumyantsev VG, Timerbulatov VM, Fomenko OY, Khubezov DA, Chashkova EY, Chibisov GI, Shapina MV, Sheptulin AA, Shifrin OS, Trukhmanov AS, Alekseeva OP, Alekseenko SA, Baranovsky AY, Zolnikova OY, Korochanskaya NV, Mammayev SN, Khlynov IB, Tsukanov VV. Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;31:74-95. [DOI: 10.22416/1382-4376-2021-31-5-74-95] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
7 Ohia SE, Njie-mbye YF, Opere CA, Ngele K, Muili F, Okolie A, Bush L. Current trend in the pharmacotherapy of digestive disorders. Nutrition and Functional Foods in Boosting Digestion, Metabolism and Immune Health 2022. [DOI: 10.1016/b978-0-12-821232-5.00032-x] [Reference Citation Analysis]
8 Mishima Y, Ishihara S. Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome. Int J Mol Sci 2021;22:10235. [PMID: 34638577 DOI: 10.3390/ijms221910235] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
9 Liu G, Li S, Chen N, Zhao Z, Guo M, Liu H, Feng J, Zhang D, Yao Z, Hu B. Inter-hemispheric Functional Connections Are More Vulnerable to Attack Than Structural Connection in Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil 2021;27:426-35. [PMID: 34210908 DOI: 10.5056/jnm20134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Moriya N, Yamagishi N, Goto T, Otabi H, Nira-kimoto H, Toyoda A, Suzuki C. The Effects of Chronic Social Defeat Stress on Solid Gastric Emptying and Defecation in C57BL/6J Mice. JARQ 2021;55:77-83. [DOI: 10.6090/jarq.55.77] [Reference Citation Analysis]
11 Sharbafchi MR, Afshar H, Adhamian P, Feizi A, Daghaghzadeh H, Adibi P. Effects of venlafaxine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome. J Res Med Sci 2020;25:115. [PMID: 33912225 DOI: 10.4103/jrms.JRMS_699_19] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Person H, Keefer L. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110209. [PMID: 33326819 DOI: 10.1016/j.pnpbp.2020.110209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
13 Skonieczna-Żydecka K, Jakubczyk K, Maciejewska-Markiewicz D, Janda K, Kaźmierczak-Siedlecka K, Kaczmarczyk M, Łoniewski I, Marlicz W. Gut Biofactory-Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review. Nutrients 2020;12:E3369. [PMID: 33139656 DOI: 10.3390/nu12113369] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
14 Wang B, Luo QQ, Li Q, Cheng L, Chen SL. Daily Short Message Service Reminders Increase Treatment Compliance and Efficacy in Outpatients with Functional Dyspepsia: a Prospective Randomized Controlled Trial. J Gen Intern Med 2020;35:2925-31. [PMID: 32779141 DOI: 10.1007/s11606-020-06088-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Li X, Qiu W, Da X, Hou Y, Ma Q, Wang T, Zhou X, Song M, Bian Q, Chen J. A combination of depression and liver Qi stagnation and spleen deficiency syndrome using a rat model. Anat Rec 2020;303:2154-67. [DOI: 10.1002/ar.24388] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
16 Juza R, Vlcek P, Mezeiova E, Musilek K, Soukup O, Korabecny J. Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders. Med Res Rev 2020;40:1593-678. [PMID: 32115745 DOI: 10.1002/med.21666] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
17 Mikocka-Walus A, Ford AC, Drossman DA. Antidepressants in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:184-92. [PMID: 32071420 DOI: 10.1038/s41575-019-0259-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
18 Qin D, Yue L, Xue B, Chen M, Tang TC, Zheng H. Pharmacological treatments for patients with irritable bowel syndrome: An umbrella review of systematic reviews and meta-analyses. Medicine (Baltimore) 2019;98:e15920. [PMID: 31393342 DOI: 10.1097/MD.0000000000015920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Ivashkin VT, Okhlobystina OZ, Mayevskaya MV, Shifrin OS, Mamieva ZA, Azimova YE. Dynamics of Somatic and Comorbid Mental Disorders (Distress, Anxiety, Somatisation and Depression) in Patients with Irritable Bowel Syndrome during Therapy with Alimemazine: Results of an Non-Interventional Observational Programme (“Terra”). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2019;28:38-50. [DOI: 10.22416/1382-4376-2018-28-6-38-50] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Moayyedi P, Andrews CN, MacQueen G, Korownyk C, Marsiglio M, Graff L, Kvern B, Lazarescu A, Liu L, Paterson WG, Sidani S, Vanner S. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). J Can Assoc Gastroenterol 2019;2:6-29. [PMID: 31294724 DOI: 10.1093/jcag/gwy071] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 14.3] [Reference Citation Analysis]
21 Sobin WH. How to Use Central Neuromodulators (CNs) to Help Manage Patients with Disorders of Gut-Brain Interaction (DGBI). Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction 2019. [DOI: 10.1007/978-3-030-18218-2_2] [Reference Citation Analysis]
22 Sobin WH. The Gut-Brain Connection and Its Significance to Gastroenterologists. Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction 2019. [DOI: 10.1007/978-3-030-18218-2_1] [Reference Citation Analysis]
23 Alharbi SH, Alateeq FA, Alshammari KI, Alshammri ASS, Alabdali NAN, Alsulaiman MAS, Algothi SMI, Altoraifi AS, Almutairi MQ, Ahmed HG. Irritable Bowel Syndrome and Dietary Habits in Northern Saudi Arabia. Health 2019;11:289-97. [DOI: 10.4236/health.2019.113025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R. Irritable bowel syndrome: the clinical approach. Panminerva Med. 2018;60:213-222. [PMID: 30257542 DOI: 10.23736/s0031-0808.18.03541-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
25 Xu Y, Cui SY, Ma Q, Shi J, Yu Y, Li JX, Zheng L, Zhang Y, Si JM, Yu YC. trans-Resveratrol Ameliorates Stress-Induced Irritable Bowel Syndrome-Like Behaviors by Regulation of Brain-Gut Axis. Front Pharmacol 2018;9:631. [PMID: 29962949 DOI: 10.3389/fphar.2018.00631] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
26 Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol 2018;15:168-80. [PMID: 29139482 DOI: 10.1038/nrgastro.2017.141] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 13.6] [Reference Citation Analysis]
27 Weaver KR, Melkus GD, Fletcher J, Henderson WA. Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome. Biol Res Nurs 2018;20:312-20. [PMID: 29402137 DOI: 10.1177/1099800418756733] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
28 Wang D, Zhang X, Zhang X, Huang Z, Song Y. Magnetic resonance imaging analysis of brain function in patients with irritable bowel syndrome. BMC Gastroenterol 2017;17:148. [PMID: 29216847 DOI: 10.1186/s12876-017-0673-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
29 Carruthers E, Stern J. Functional gastrointestinal disorders and psychotropic medication. Functional Gastrointestinal Disorders 2017. [DOI: 10.4324/9781315670355-24] [Reference Citation Analysis]
30 Weaver KR, Melkus GD, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017;117:48-55. [PMID: 28541989 DOI: 10.1097/01.NAJ.0000520253.57459.01] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
31 Sobin WH, Heinrich TW, Drossman DA. Central Neuromodulators for Treating Functional GI Disorders: A Primer. Am J Gastroenterol 2017;112:693-702. [PMID: 28349992 DOI: 10.1038/ajg.2017.57] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
32 Corsetti M, Whorwell P. New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline. Expert Rev Gastroenterol Hepatol 2017;11:285-92. [PMID: 28276811 DOI: 10.1080/17474124.2017.1298442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
33 Carmona-sánchez R, Icaza-chávez M, Bielsa-fernández M, Gómez-escudero O, Bosques-padilla F, Coss-adame E, Esquivel-ayanegui F, Flores-rendón Á, González-martínez M, Huerta-iga F, López-colombo A, Méndez-gutiérrez T, Noble-lugo A, Nogueira-de Rojas J, Raña-garibay R, Remes-troche J, Roesch-dietlen F, Schmulson M, Soto-pérez J, Tamayo J, Uscanga L, Valdovinos M, Valerio-ureña J, Zavala-solares M. Consenso mexicano sobre el síndrome de intestino irritable. Revista de Gastroenterología de México 2016;81:149-67. [DOI: 10.1016/j.rgmx.2016.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Carmona-sánchez R, Icaza-chávez M, Bielsa-fernández M, Gómez-escudero O, Bosques-padilla F, Coss-adame E, Esquivel-ayanegui F, Flores-rendón Á, González-martínez M, Huerta-iga F, López-colombo A, Méndez-gutiérrez T, Noble-lugo A, Nogueira-de Rojas J, Raña-garibay R, Remes-troche J, Roesch-dietlen F, Schmulson M, Soto-pérez J, Tamayo J, Uscanga L, Valdovinos M, Valerio-ureña J, Zavala-solares M. The Mexican consensus on irritable bowel syndrome. Revista de Gastroenterología de México (English Edition) 2016;81:149-167. [DOI: 10.1016/j.rgmxen.2016.01.004] [Reference Citation Analysis]
35 Weaver KR, Sherwin LB, Walitt B, Melkus GD, Henderson WA. Neuroimaging the brain-gut axis in patients with irritable bowel syndrome. World J Gastrointest Pharmacol Ther 2016; 7(2): 320-333 [PMID: 27158548 DOI: 10.4292/wjgpt.v7.i2.320] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
36 Jang SH, Ryu HS, Choi SC, Lee SY. Psychological factors influence the overlap syndrome in functional gastrointestinal disorders and their effect on quality of life among firefighters in South Korea. J Dig Dis 2016;17:236-43. [PMID: 26896638 DOI: 10.1111/1751-2980.12330] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
37 Keefer L, Drossman DA, Guthrie E, Simrén M, Tillisch K, Olden K, Whorwell PJ. Centrally Mediated Disorders of Gastrointestinal Pain. Gastroenterology 2016:S0016-5085(16)00225-0. [PMID: 27144628 DOI: 10.1053/j.gastro.2016.02.034] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 11.9] [Reference Citation Analysis]
38 Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, Murphy TB, Naliboff BD, Levy RL. Biopsychosocial Aspects of Functional Gastrointestinal Disorders. Gastroenterology 2016:S0016-5085(16)00218-3. [PMID: 27144624 DOI: 10.1053/j.gastro.2016.02.027] [Cited by in Crossref: 236] [Cited by in F6Publishing: 239] [Article Influence: 33.7] [Reference Citation Analysis]
39 Johnson AC, Greenwood-Van Meerveld B. The Pharmacology of Visceral Pain. Adv Pharmacol 2016;75:273-301. [PMID: 26920016 DOI: 10.1016/bs.apha.2015.11.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
40 Farmer AD, Aziz Q. The Brain–Gut Axis. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Zhu L, Huang D, Shi L, Liang L, Xu T, Chang M, Chen W, Wu D, Zhang F, Fang X. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2015;13:49. [PMID: 25925746 DOI: 10.1186/s12955-015-0243-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
42 Leigh H. Anxiety and Anxiety Disorders. Handbook of Consultation-Liaison Psychiatry 2015. [DOI: 10.1007/978-3-319-11005-9_14] [Reference Citation Analysis]
43 Jo Y. Effect of Amitriptyline in Patients with Functional Dyspepsia. Korean J Gastroenterol 2015;66:245. [DOI: 10.4166/kjg.2015.66.4.245] [Reference Citation Analysis]
44 Al Omran Y, Aziz Q. The brain-gut axis in health and disease. Adv Exp Med Biol 2014;817:135-53. [PMID: 24997032 DOI: 10.1007/978-1-4939-0897-4_6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
45 Coss-Adame E, Rao SS. Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings. Curr Gastroenterol Rep. 2014;16:379. [PMID: 24595616 DOI: 10.1007/s11894-014-0379-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
46 Tarantino S, Capuano A, Torriero R, Citti M, Vollono C, Gentile S, Vigevano F, Valeriani M. Migraine Equivalents as Part of Migraine Syndrome in Childhood. Pediatric Neurology 2014;51:645-9. [DOI: 10.1016/j.pediatrneurol.2014.07.018] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
47 Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterol Motil 2014;26:1642-50. [PMID: 25244442 DOI: 10.1111/nmo.12444] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
48 Jing F, Zhang J. Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders. Dig Dis Sci 2014;59:2642-8. [PMID: 24916714 DOI: 10.1007/s10620-014-3244-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
49 Vázquez GH. The impact of psychopharmacology on contemporary clinical psychiatry. Can J Psychiatry 2014;59:412-6. [PMID: 25161065 DOI: 10.1177/070674371405900803] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
50 Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol 2014; 20(39): 14126-14131 [PMID: 25339801 DOI: 10.3748/wjg.v20.i39.14126] [Cited by in CrossRef: 151] [Cited by in F6Publishing: 161] [Article Influence: 16.8] [Reference Citation Analysis]
51 Lan L, Chen YL, Zhang H, Jia BL, Chu YJ, Wang J, Tang SX, Xia GD. Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety. World J Gastroenterol 2014; 20(32): 11422-11428 [PMID: 25170231 DOI: 10.3748/wjg.v20.i32.11422] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
52 Kurlander JE, Drossman DA. Diagnosis and treatment of narcotic bowel syndrome. Nat Rev Gastroenterol Hepatol 2014;11:410-8. [PMID: 24751914 DOI: 10.1038/nrgastro.2014.53] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
53 Drossman DA. Treatment of residual inflammatory bowel disease symptoms with low-dose tricyclic antidepressants: why not? J Clin Gastroenterol 2014;48:390-2. [PMID: 24714103 DOI: 10.1097/MCG.0000000000000098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
54 Vanheel H, Tack J. Therapeutic options for functional dyspepsia. Dig Dis 2014;32:230-4. [PMID: 24732188 DOI: 10.1159/000358111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
55 Chang FY. Irritable bowel syndrome: The evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol 2014; 20(10): 2499-2514 [PMID: 24627587 DOI: 10.3748/wjg.v20.i10.2499] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
56 Anastasi JK, Capili B, Chang M. Managing irritable bowel syndrome. Am J Nurs 2013;113:42-52; quiz 54, 53. [PMID: 23764698 DOI: 10.1097/01.NAJ.0000431911.65473.35] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
57 Yacob D, Di Lorenzo C. How to Deal with Pediatric Functional Gastrointestinal Disorders. Curr Pediatr Rep 2013;1:198-205. [DOI: 10.1007/s40124-013-0018-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Pae CU, Lee SJ, Han C, Patkar AA, Masand PS. Atypical antipsychotics as a possible treatment option for irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22:565-572. [PMID: 23506326 DOI: 10.1517/13543784.2013.782392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]